Cardinal Health Inc (CAH) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Cardinal Health Inc (NYSE:CAH) have been assigned an average recommendation of “Hold” from the twenty analysts that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $72.99.

A number of analysts have recently issued reports on CAH shares. ValuEngine cut Cardinal Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Royal Bank of Canada started coverage on Cardinal Health in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 price objective on the stock. Argus cut Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Deutsche Bank started coverage on Cardinal Health in a research report on Monday, December 4th. They issued a “hold” rating and a $64.00 price target on the stock. Finally, Morgan Stanley cut Cardinal Health from an “equal weight” rating to an “underweight” rating in a research report on Monday, November 20th.

Cardinal Health (CAH) traded up $2.38 on Friday, hitting $71.49. The stock had a trading volume of 4,045,701 shares, compared to its average volume of 3,323,189. The company has a market capitalization of $22,010.00, a PE ratio of 20.84, a PEG ratio of 1.84 and a beta of 0.85. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35. Cardinal Health has a 1-year low of $54.66 and a 1-year high of $84.88.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a return on equity of 6.84% and a net margin of 0.36%. Cardinal Health’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.24 earnings per share. analysts anticipate that Cardinal Health will post 4.95 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be given a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Friday, December 29th. Cardinal Health’s dividend payout ratio (DPR) is 53.94%.

Large investors have recently made changes to their positions in the business. Ameriprise Financial Inc. boosted its stake in Cardinal Health by 71.4% in the second quarter. Ameriprise Financial Inc. now owns 3,557,123 shares of the company’s stock worth $277,191,000 after purchasing an additional 1,482,285 shares in the last quarter. BlackRock Inc. boosted its stake in Cardinal Health by 6.5% in the second quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock worth $1,779,958,000 after purchasing an additional 1,398,496 shares in the last quarter. American Century Companies Inc. boosted its stake in Cardinal Health by 58.7% in the third quarter. American Century Companies Inc. now owns 2,976,776 shares of the company’s stock worth $199,206,000 after purchasing an additional 1,100,507 shares in the last quarter. HealthCor Management L.P. acquired a new position in Cardinal Health in the second quarter worth $84,496,000. Finally, Pzena Investment Management LLC boosted its stake in Cardinal Health by 70.6% in the third quarter. Pzena Investment Management LLC now owns 1,806,522 shares of the company’s stock worth $120,892,000 after purchasing an additional 747,718 shares in the last quarter. Hedge funds and other institutional investors own 88.35% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/04/cardinal-health-inc-cah-receives-consensus-recommendation-of-hold-from-brokerages.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply